These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 31804459)
1. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma. Hou Y; Wang Z; Huang S; Sun C; Zhao J; Shi J; Li Z; Wang Z; He X; Tam NL; Wu L Cell Death Dis; 2019 Dec; 10(12):929. PubMed ID: 31804459 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma. Tang J; Liu J; Li J; Liang Z; Zeng K; Li H; Zhao Z; Zhou L; Jiang N Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760206 [TBL] [Abstract][Full Text] [Related]
3. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma. Tian F; Cai D Gene; 2022 Jan; 807():145964. PubMed ID: 34530087 [TBL] [Abstract][Full Text] [Related]
4. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma. Huang S; Zhang C; Sun C; Hou Y; Zhang Y; Tam NL; Wang Z; Yu J; Huang B; Zhuang H; Zhou Z; Ma Z; Sun Z; He X; Zhou Q; Hou B; Wu L Aging (Albany NY); 2020 Feb; 12(3):3025-3041. PubMed ID: 32045367 [TBL] [Abstract][Full Text] [Related]
5. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma. Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896 [TBL] [Abstract][Full Text] [Related]
6. Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma. Lin J; Hou Y; Huang S; Wang Z; Sun C; Wang Z; He X; Tam NL; Wu C; Wu L Mol Carcinog; 2019 Feb; 58(2):293-304. PubMed ID: 30334580 [TBL] [Abstract][Full Text] [Related]
7. Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein. Zhu Y; Cui J; Liu J; Hua W; Wei W; Sun G Cancer Med; 2020 May; 9(10):3592-3603. PubMed ID: 32160655 [TBL] [Abstract][Full Text] [Related]
8. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway. Huang DH; Jian J; Li S; Zhang Y; Liu LZ Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175 [TBL] [Abstract][Full Text] [Related]
9. Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression. Yu Y; Chen X; Zhang W; Liu J Biomed Res Int; 2021; 2021():4051192. PubMed ID: 34957303 [TBL] [Abstract][Full Text] [Related]
10. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma. Liu L; Yang X; Li NF; Lin L; Luo H Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588 [No Abstract] [Full Text] [Related]
11. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling. Jiang J; Xu B; Zheng Y; Guo X; Chen F Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway. Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631 [TBL] [Abstract][Full Text] [Related]
13. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway. He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229 [TBL] [Abstract][Full Text] [Related]
14. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma. Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125 [TBL] [Abstract][Full Text] [Related]
15. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway. Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361 [TBL] [Abstract][Full Text] [Related]
16. The competing endogenous circular RNA ADAMTS14 suppressed hepatocellular carcinoma progression through regulating microRNA-572/regulator of calcineurin 1. Song C; Li D; Liu H; Sun H; Liu Z; Zhang L; Hu Y J Cell Physiol; 2019 Mar; 234(3):2460-2470. PubMed ID: 30317540 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis. Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634 [TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
19. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma. Zhang C; Chen B; Jiao A; Li F; Sun N; Zhang G; Zhang J BMC Cancer; 2018 Nov; 18(1):1179. PubMed ID: 30486878 [TBL] [Abstract][Full Text] [Related]
20. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53. Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]